ea0048p1 | Poster Presentations | SFEEU2017
McGowan Barbara
, Fujioka Ken
, Greenway Frank
, Krempf Michel
, Le Roux Carel
, Vettor Roberto
, Lilleore Soren
, Astrup Arne
Aims/objectives: Obesity and prediabetes are risk factors for developing T2D. 510% weight-loss can reduce risk of developing T2D by >50%. The 3-year part of this phase 3 trial investigated effects of liraglutide 3.0 mg, as adjunct to diet+exercise, in delaying onset of T2D over 3 years, body-weight and cardiometabolic risk factors in adults with obesity or overweight with comorbidities, and diagnosed with prediabetes at screening.Methods: Indiv...